{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:58:51Z","timestamp":1780772331166,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003782","name":"Institute of Postgraduate Studies, Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["A305\u2011KR\u2011AKH002\u20110004401005\u20110000"],"award-info":[{"award-number":["A305\u2011KR\u2011AKH002\u20110004401005\u20110000"]}],"id":[{"id":"10.13039\/501100003782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003782","name":"Institute of Postgraduate Studies, Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["(Grant No. FRGS\/1\/2024\/SKKO3\/USM\/02\/1)"],"award-info":[{"award-number":["(Grant No. FRGS\/1\/2024\/SKKO3\/USM\/02\/1)"]}],"id":[{"id":"10.13039\/501100003782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00705-026-06637-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:28:34Z","timestamp":1778509714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated in silico\u2013in vitro identification of high-affinity TCR-Like antibodies targeting HPV18 E6\/E7 for cervical cancer detection"],"prefix":"10.1007","volume":"171","author":[{"given":"Bassam Ali","family":"Sachit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehasri Selva","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Jun","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4874-600X","authenticated-orcid":false,"given":"Venugopal","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"6637_CR1","doi-asserted-by":"crossref","unstructured":"Doghish AS et al (2023) miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathology-Research Pract, : p. 154386","DOI":"10.1016\/j.prp.2023.154386"},{"key":"6637_CR2","doi-asserted-by":"crossref","unstructured":"Fan Q et al (2021) HPV-16\/18 E6\u2010induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1. Molecular Carcinog 60(5):313\u2013330","DOI":"10.1002\/mc.23292"},{"issue":"39","key":"6637_CR3","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.2174\/0929867327666201111145546","volume":"28","author":"R Malla","year":"2021","unstructured":"Malla R, Kamal MA (2021) E6 and E7 oncoproteins: Potential targets of cervical cancer. Curr Med Chem 28(39):8163\u20138181","journal-title":"Curr Med Chem"},{"issue":"4","key":"6637_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4236\/ajmb.2023.134019","volume":"13","author":"TM Zohoncon","year":"2023","unstructured":"Zohoncon TM et al (2023) Detection of Human Papillomavirus DNA and E6\/E7 mRNA from HPV Genotypes 16, 18, 31 and 33 in Histologically Confirmed Cases of Cervical Cancer and Precancerous Lesions in Burkina Faso. Am J Mol Biology 13(4):276\u2013290","journal-title":"Am J Mol Biology"},{"key":"6637_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10989-020-10089-5","volume":"27","author":"B Bahmani","year":"2021","unstructured":"Bahmani B et al (2021) HPV16-E7 protein T cell epitope prediction and global therapeutic peptide vaccine design based on human leukocyte antigen frequency: an in-silico study. Int J Pept Res Ther 27:365\u2013378","journal-title":"Int J Pept Res Ther"},{"key":"6637_CR6","first-page":"107","volume-title":"Designing of CD8\u2009+\u2009and CD8+-overlapped CD4\u2009+\u2009epitope vaccine by targeting late and early proteins of human papillomavirus","author":"S Kaliamurthi","year":"2018","unstructured":"Kaliamurthi S et al (2018) Designing of CD8\u2009+\u2009and CD8+-overlapped CD4\u2009+\u2009epitope vaccine by targeting late and early proteins of human papillomavirus. Targets and Therapy, Biologics, pp 107\u2013125"},{"issue":"2","key":"6637_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ijc.28984","volume":"136","author":"KM Elfstr\u00f6m","year":"2015","unstructured":"Elfstr\u00f6m KM et al (2015) Long-term HPV type\u2010specific risks for ASCUS and LSIL: A 14\u2010year follow\u2010up of a randomized primary HPV screening trial. Int J Cancer 136(2):350\u2013359","journal-title":"Int J Cancer"},{"issue":"1","key":"6637_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/jtgga.2016.0138","volume":"18","author":"C Cort\u00e9s-Alaguero","year":"2017","unstructured":"Cort\u00e9s-Alaguero C et al (2017) Do clinical data and human papilloma virus genotype influence spontaneous regression in grade I cervical intraepithelial neoplasia? J Turkish German Gynecol Association 18(1):1","journal-title":"J Turkish German Gynecol Association"},{"issue":"20","key":"6637_CR9","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMsa044278","volume":"353","author":"SJ Goldie","year":"2005","unstructured":"Goldie SJ et al (2005) Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353(20):2158\u20132168","journal-title":"N Engl J Med"},{"issue":"14","key":"6637_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan R et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360(14):1385\u20131394","journal-title":"N Engl J Med"},{"issue":"3","key":"6637_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.31557\/APJCP.2020.21.3.853","volume":"21","author":"R Romli","year":"2020","unstructured":"Romli R, Saddki N, Mokhtar N (2020) Effectiveness of a health education program to improve knowledge and attitude towards cervical cancer and pap smear: a controlled community trial in Malaysia. Asian Pac J cancer prevention: APJCP 21(3):853","journal-title":"Asian Pac J cancer prevention: APJCP"},{"issue":"6","key":"6637_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5306\/wjco.v6.i6.281","volume":"6","author":"R Catarino","year":"2015","unstructured":"Catarino R et al (2015) Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol 6(6):281","journal-title":"World J Clin Oncol"},{"key":"6637_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gore.2018.02.004","volume":"24","author":"NVQ Huy","year":"2018","unstructured":"Huy NVQ et al (2018) The value of visual inspection with acetic acid and Pap smear in cervical cancer screening program in low resource settings\u2013A population-based study. Gynecologic Oncol Rep 24:18\u201320","journal-title":"Gynecologic Oncol Rep"},{"key":"6637_CR14","first-page":"p842037","volume":"2014(1)","author":"E Bengtsson","year":"2014","unstructured":"Bengtsson E (2014) P <>Malm Screening for cervical cancer using automated analysis of PAP-smears. Comput Math Methods Med 2014(1) p842037","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"6637_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/JCLGTP.JCLGTP_11_24","volume":"2","author":"A Kumar","year":"2024","unstructured":"Kumar A, Suri V, Dabral A (2024) Role of Conventional Pap Smear in Current Times. J Colposcopy Lower Genit Tract Pathol 2(2):60\u201364","journal-title":"J Colposcopy Lower Genit Tract Pathol"},{"issue":"11","key":"6637_CR16","doi-asserted-by":"publisher","first-page":"e0188592","DOI":"10.1371\/journal.pone.0188592","volume":"12","author":"CE Cocuzza","year":"2017","unstructured":"Cocuzza CE et al (2017) Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia. PLoS ONE 12(11):e0188592","journal-title":"PLoS ONE"},{"key":"6637_CR17","doi-asserted-by":"publisher","first-page":"624230","DOI":"10.3389\/fimmu.2021.624230","volume":"12","author":"S Christley","year":"2021","unstructured":"Christley S et al (2021) T cell receptor repertoires acquired via routine pap testing may help refine cervical cancer and precancer risk estimates. Front Immunol 12:624230","journal-title":"Front Immunol"},{"issue":"1","key":"6637_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12929-022-00864-5","volume":"29","author":"S Peng","year":"2022","unstructured":"Peng S et al (2022) Identification of human MHC-I HPV18 E6\/E7-specific CD8\u2009+\u2009T cell epitopes and generation of an HPV18 E6\/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice. J Biomed Sci 29(1):80","journal-title":"J Biomed Sci"},{"issue":"8","key":"6637_CR19","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ijc.32156","volume":"145","author":"A Ferrera","year":"2019","unstructured":"Ferrera A et al (2019) Performance of an HPV 16\/18 E6 oncoprotein test for detection of cervical precancer and cancer. Int J Cancer 145(8):2042\u20132050","journal-title":"Int J Cancer"},{"issue":"15","key":"6637_CR20","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-16-3217","volume":"23","author":"A Altmann","year":"2017","unstructured":"Altmann A et al (2017) Identification of a novel ITG\u03b1v\u03b26-binding peptide using protein separation and phage display. Clin Cancer Res 23(15):4170\u20134180","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6637_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/v13020178","volume":"13","author":"K Nagano","year":"2021","unstructured":"Nagano K, Tsutsumi Y (2021) Phage display technology as a powerful platform for antibody drug discovery. Viruses 13(2):178","journal-title":"Viruses"},{"issue":"2","key":"6637_CR22","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1038\/jid.2013.521","volume":"134","author":"CM Hammers","year":"2014","unstructured":"Hammers CM, Stanley JR (2014) Antibody phage display: technique and applications. J Invest Dermatol 134(2):e17","journal-title":"J Invest Dermatol"},{"issue":"3","key":"6637_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antib2030517","volume":"2","author":"M Cohen","year":"2013","unstructured":"Cohen M, Reiter Y (2013) T-cell receptor-like antibodies: targeting the intracellular proteome therapeutic potential and clinical applications. Antibodies 2(3):517\u2013534","journal-title":"Antibodies"},{"issue":"2","key":"6637_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3892\/mmr.2025.13583","volume":"32","author":"BA Sachit","year":"2025","unstructured":"Sachit BA et al (2025) Development of an innovative approach for early diagnosis of cervical cancer using TCR-like antibodies targeting HPV18 E6 and E7 peptides. Mol Med Rep 32(2):218","journal-title":"Mol Med Rep"},{"key":"6637_CR25","doi-asserted-by":"crossref","unstructured":"Waterhouse AM, Studer G, Robin X, Bienert S, Tauriello G, Schwede T (2024) The structure assessment web server: for proteins, complexes and more. Nucleic Acids Res 52(W1):W318\u2013W32","DOI":"10.1093\/nar\/gkae270"},{"issue":"6","key":"6637_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA et al (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845\u2013858","journal-title":"Nat Protoc"},{"issue":"2","key":"6637_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D et al (2017) The ClusPro web server for protein\u2013protein docking. Nat Protoc 12(2):255\u2013278","journal-title":"Nat Protoc"},{"issue":"12","key":"6637_CR28","doi-asserted-by":"publisher","first-page":"e4473","DOI":"10.1002\/pro.4473","volume":"31","author":"RA Laskowski","year":"2022","unstructured":"Laskowski RA (2022) PDBsum 1: A standalone program for generating PDBsum analyses. Protein Sci 31(12):e4473","journal-title":"Protein Sci"},{"key":"6637_CR29","first-page":"154","volume":"8","author":"MZ Ahmed","year":"2021","unstructured":"Ahmed MZ et al (2021) In silico molecular docking analysis of limonene with the fat mass and obesity-associated protein by using autodock vina. Sci J Inf 8:154\u2013160","journal-title":"Sci J Inf"},{"issue":"4","key":"6637_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21873\/cgp.20036","volume":"14","author":"KI Pappa","year":"2017","unstructured":"Pappa KI et al (2017) Proteomic analysis of normal and cancer cervical cell lines reveals deregulation of cytoskeleton-associated proteins. Cancer Genomics Proteomics 14(4):253\u2013266","journal-title":"Cancer Genomics Proteomics"},{"key":"6637_CR31","doi-asserted-by":"crossref","unstructured":"Moln\u00e1r E (2019) Cell-based enzyme-linked immunosorbent assay (cell-ELISA) analysis of native and recombinant glutamate receptors. Glutamate receptors: Methods and protocols. Methods Mol Biol 1941:47\u201354","DOI":"10.1007\/978-1-4939-9077-1_4"},{"issue":"7988","key":"6637_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41586-023-06706-0","volume":"623","author":"M Yarmarkovich","year":"2023","unstructured":"Yarmarkovich M et al (2023) Targeting of intracellular oncoproteins with peptide-centric CARs. Nature 623(7988):820\u2013827","journal-title":"Nature"},{"key":"6637_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00347-013-2861-7","volume":"110","author":"T Lapp","year":"2013","unstructured":"Lapp T et al (2013) Human leukocyte antigen (HLA) system in ophthalmology. Der Ophthalmologe 110:849\u2013861","journal-title":"Der Ophthalmologe"},{"issue":"4","key":"6637_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/138920206778426951","volume":"7","author":"T Lichtor","year":"2006","unstructured":"Lichtor T, Glick RP, Cohen EP (2006) Antigenic Differences Between Normal and Malignant Cells as a Basis for Treatment of Intracerebral Neoplasms Using a DNA-Based Vaccine. Curr Genom 7(4):253\u2013261","journal-title":"Curr Genom"},{"key":"6637_CR35","doi-asserted-by":"crossref","unstructured":"Dass SA et al (2021) The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy, vol 17. Human Vaccines & Immunotherapeutics, pp 2981\u20132994. 9","DOI":"10.1080\/21645515.2021.1913960"},{"issue":"8","key":"6637_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41419-018-0824-2","volume":"9","author":"E Dang","year":"2018","unstructured":"Dang E et al (2018) BAP31, a newly defined cancer\/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression. Cell Death Dis 9(8):791","journal-title":"Cell Death Dis"},{"key":"6637_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3389\/fonc.2019.01237","volume":"9","author":"J Cheng","year":"2019","unstructured":"Cheng J et al (2019) Understanding the mechanisms of resistance to CAR T-cell therapy in malignancies. Front Oncol 9:1237","journal-title":"Front Oncol"},{"issue":"176","key":"6637_CR38","doi-asserted-by":"publisher","first-page":"176ra33","DOI":"10.1126\/scitranslmed.3005661","volume":"5","author":"T Dao","year":"2013","unstructured":"Dao T et al (2013) Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Sci Transl Med 5(176):176ra33\u2013176ra33","journal-title":"Sci Transl Med"},{"issue":"14","key":"6637_CR39","doi-asserted-by":"publisher","first-page":"7969","DOI":"10.1073\/pnas.97.14.7969","volume":"97","author":"P Chames","year":"2000","unstructured":"Chames P et al (2000) Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1\u2013MAGE-A1 from a nonimmunized phage-Fab library. Proc Natl Acad Sci 97(14):7969\u20137974","journal-title":"Proc Natl Acad Sci"},{"issue":"25","key":"6637_CR40","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1016\/j.vaccine.2008.02.025","volume":"26","author":"FA Neethling","year":"2008","unstructured":"Neethling FA et al (2008) Assessing vaccine potency using TCRmimic antibodies. Vaccine 26(25):3092\u20133102","journal-title":"Vaccine"},{"issue":"10","key":"6637_CR41","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1158\/0008-5472.CAN-16-3247","volume":"77","author":"D Li","year":"2017","unstructured":"Li D et al (2017) Development of a T-cell receptor mimic antibody against wild-type p53 for cancer immunotherapy. Cancer Res 77(10):2699\u20132711","journal-title":"Cancer Res"},{"issue":"8","key":"6637_CR42","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.4049\/jimmunol.177.8.5088","volume":"177","author":"JA Weidanz","year":"2006","unstructured":"Weidanz JA et al (2006) Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol 177(8):5088\u20135097","journal-title":"J Immunol"},{"issue":"6","key":"6637_CR43","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/eji.200737524","volume":"38","author":"M Epel","year":"2008","unstructured":"Epel M et al (2008) Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor\u2010like human recombinant antibodies. Eur J Immunol 38(6):1706\u20131720","journal-title":"Eur J Immunol"},{"issue":"6","key":"6637_CR44","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.4049\/jimmunol.177.6.4187","volume":"177","author":"VP Wittman","year":"2006","unstructured":"Wittman VP et al (2006) Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death. J Immunol 177(6):4187\u20134195","journal-title":"J Immunol"},{"issue":"20","key":"6637_CR45","first-page":"5835","volume":"62","author":"CJ Cohen","year":"2002","unstructured":"Cohen CJ et al (2002) Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res 62(20):5835\u20135844","journal-title":"Cancer Res"},{"issue":"11","key":"6637_CR46","first-page":"3184","volume":"62","author":"A Lev","year":"2002","unstructured":"Lev A et al (2002) Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit. Cancer Res 62(11):3184\u20133194","journal-title":"Cancer Res"},{"issue":"21","key":"6637_CR47","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/sj.gt.3301570","volume":"8","author":"R Willemsen","year":"2001","unstructured":"Willemsen R et al (2001) A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes. Gene Ther 8(21):1601\u20131608","journal-title":"Gene Ther"},{"issue":"4","key":"6637_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA et al (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8(4):299\u2013308","journal-title":"Nat Rev Cancer"},{"key":"6637_CR49","doi-asserted-by":"crossref","unstructured":"Andersen PS et al (1996) A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proceedings of the National Academy of Sciences, 93(5): pp. 1820\u20131824","DOI":"10.1073\/pnas.93.5.1820"},{"key":"6637_CR50","first-page":"302","volume":"4","author":"I Sela-Culang","year":"2013","unstructured":"Sela-Culang I, Kunik V, Ofran Y (2013) Struct basis antibody-antigen Recognit Front Immunol 4:302","journal-title":"Struct basis antibody-antigen Recognit Front Immunol"},{"issue":"1","key":"6637_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum JS, Wearsch PA, Cresswell P (2013) Pathways of antigen processing. Annu Rev Immunol 31(1):443\u2013473","journal-title":"Annu Rev Immunol"},{"key":"6637_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.crstbi.2020.11.002","volume":"3","author":"KP Tan","year":"2021","unstructured":"Tan KP et al (2021) Peptide bond planarity constrains hydrogen bond geometry and influences secondary structure conformations. Curr Res Struct Biology 3:1\u20138","journal-title":"Curr Res Struct Biology"},{"issue":"1","key":"6637_CR53","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41598-020-58825-7","volume":"10","author":"AS Panja","year":"2020","unstructured":"Panja AS, Maiti S, Bandyopadhyay B (2020) Protein stability governed by its structural plasticity is inferred by physicochemical factors and salt bridges. Sci Rep 10(1):1822","journal-title":"Sci Rep"},{"key":"6637_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04335-w","volume":"22","author":"R Ehrlich","year":"2021","unstructured":"Ehrlich R et al (2021) SwarmTCR: a computational approach to predict the specificity of T cell receptors. BMC Bioinformatics 22:1\u201314","journal-title":"BMC Bioinformatics"},{"key":"6637_CR55","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijbiomac.2019.08.066","volume":"140","author":"C Li","year":"2019","unstructured":"Li C, Arakawa T (2019) Agarose native gel electrophoresis of proteins. Int J Biol Macromol 140:668\u2013671","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"6637_CR56","first-page":"2277","volume":"53","author":"N Yoshihara","year":"1995","unstructured":"Yoshihara N (1995) ELISA for diagnosis of infections by viruses. Nihon Rinsho. Japanese J Clin Med 53(9):2277\u20132282","journal-title":"Japanese J Clin Med"},{"key":"6637_CR57","doi-asserted-by":"publisher","first-page":"707473","DOI":"10.3389\/fonc.2021.707473","volume":"11","author":"A Takahashi","year":"2021","unstructured":"Takahashi A et al (2021) Tyrosine kinase inhibitors stimulate HLA class I expression by augmenting the IFN\u03b3\/STAT1 signaling in hepatocellular carcinoma cells. Front Oncol 11:707473","journal-title":"Front Oncol"},{"issue":"2","key":"6637_CR58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gr.164806.113","volume":"24","author":"K Akagi","year":"2014","unstructured":"Akagi K et al (2014) Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24(2):185\u2013199","journal-title":"Genome Res"},{"issue":"1","key":"6637_CR59","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg M et al (2016) Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat Commun 7(1):13404","journal-title":"Nat Commun"},{"issue":"12","key":"6637_CR60","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1074\/mcp.O115.052431","volume":"14","author":"E Caron","year":"2015","unstructured":"Caron E et al (2015) Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry. Mol Cell Proteom 14(12):3105\u20133117","journal-title":"Mol Cell Proteom"},{"issue":"5","key":"6637_CR61","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.immuni.2013.08.036","volume":"39","author":"J Huang","year":"2013","unstructured":"Huang J et al (2013) A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4\u2009+\u2009T cells. Immunity 39(5):846\u2013857","journal-title":"Immunity"},{"issue":"8","key":"6637_CR62","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1158\/0008-5472.CAN-06-3986","volume":"67","author":"CJ Cohen","year":"2007","unstructured":"Cohen CJ et al (2007) Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res 67(8):3898\u20133903","journal-title":"Cancer Res"},{"issue":"4","key":"6637_CR63","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.autrev.2005.07.004","volume":"5","author":"G Denkberg","year":"2006","unstructured":"Denkberg G, Reiter Y (2006) Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun rev 5(4):252\u2013257","journal-title":"Autoimmun rev"},{"issue":"9","key":"6637_CR64","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-21-0115","volume":"20","author":"Z Duan","year":"2021","unstructured":"Duan Z, Ho M (2021) T-cell receptor mimic antibodies for cancer immunotherapy. Mol Cancer Ther 20(9):1533\u20131541","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"6637_CR65","first-page":"22","volume":"2","author":"Y Xu","year":"2019","unstructured":"Xu Y et al (2019) T-cell receptor mimic (TCRm) antibody therapeutics against intracellular proteins. Antib Ther 2(1):22\u201332","journal-title":"Antib Ther"},{"issue":"D1","key":"6637_CR66","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF et al (2020) Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 48(D1):D783\u2013D788","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"6637_CR67","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel C et al (2017) Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141(4):664\u2013670","journal-title":"Int J Cancer"},{"issue":"8","key":"6637_CR68","doi-asserted-by":"publisher","first-page":"pdb","DOI":"10.1101\/pdb.prot099689","volume":"2020","author":"SJ Rodig","year":"2020","unstructured":"Rodig SJ (2020) Fixing attached cells for staining. Cold Spring Harbor Protoc 2020(8):pdb","journal-title":"Cold Spring Harbor Protoc"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-026-06637-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:01:39Z","timestamp":1780768899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-026-06637-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6637"],"URL":"https:\/\/doi.org\/10.1007\/s00705-026-06637-x","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publications"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}